Veys Em
Impact in
- Rheumatology top 1%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Osteoarthritis Treatment and Mechanisms
- Systemic Lupus Erythematosus Research
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 23
- Spondyloarthritis Studies and Treatments 9
- Rheumatoid Arthritis Research and Therapies 9
- Osteoarthritis Treatment and Mechanisms 5
- Systemic Lupus Erythematosus Research 4
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Herman Mielants (22 shared papers)De Vos M (9 shared papers)Gust Verbruggen (12 shared papers)C Cuvelier (4 shared papers)Claude Cuvelier (4 shared papers)Stefan Goemaere (2 shared papers)Lieve Gyselbrecht (2 shared papers)Dirk Elewaut (3 shared papers)
- Journals
- PubMed (34 papers)
- Partner nations
- Belgium
In The Last Decade
Veys Em
34 papers receiving 845 citations
Peers
Comparison fields: 5 of 75
- Rheumatology 574
- Hematology 125
- Immunology 218
- Genetics 202
- Immunology and Allergy 29
Countries citing papers authored by Veys Em
This map shows the geographic impact of Veys Em's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veys Em with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veys Em more than expected).
Fields of papers citing papers by Veys Em
This network shows the impact of papers produced by Veys Em. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veys Em. The network helps show where Veys Em may publish in the future.
Co-authors
The 25 scholars most cited alongside Veys Em, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. | 2000 | 187 |
| 2 | The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. | 1995 | 150 |
| 3 | Evaluation of T cell subsets with monoclonal antibodies in patients with rheumatoid arthritis. | 1982 | 67 |
| 4 | Interferon gamma in rheumatoid arthritis--a double blind study comparing human recombinant interferon gamma with placebo. | 1988 | 52 |
| 5 | Influence of sulphated glycosaminoglycans upon proteoglycan metabolism of the synovial lining cells. | 1979 | 43 |
| 6 | HLA-B27 related arthritis and bowel inflammation. Part 1. Sulfasalazine (salazopyrin) in HLA-B27 related reactive arthritis. | 1985 | 39 |
| 7 | HLA antigens in seronegative spondylarthropathies. Reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation. | 1987 | 39 |
| 8 | Repeat ileocolonoscopy in reactive arthritis. | 1987 | 36 |
| 9 | Subclinical involvement of the gut in undifferentiated spondylarthropathies. | 1990 | 34 |
| 10 | Evaluation of T cell subsets with monoclonal antibodies in synovial fluid in rheumatoid arthritis. | 1983 | 29 |
| 11 | Intestinal mucosal permeability in inflammatory rheumatic diseases. I. Role of antiinflammatory drugs. | 1991 | 27 |
| 12 | Destructive lesions of small joints in seronegative spondylarthropathies: relation to gut inflammation. | 1990 | 23 |
| 13 | The synthesis and immobilisation of cartilage-specific proteoglycan by human chondrocytes in different concentrations of agarose. | 1990 | 23 |
| 14 | Levamisole as basic treatment of rheumatoid arthritis: longterm evaluation. | 1981 | 16 |
| 15 | Experience and recommendations for treatment schedule of levamisole in rheumatoid arthritis. | 1978 | 14 |
| 16 | HLA-B27 positive idiopathic acute anterior uveitis: a unique manifestation of subclinical gut inflammation. | 1990 | 13 |
| 17 | Influence of an oversulphated heparinoid upon hyaluronate metabolism of the human synovial cell in vivo. | 1980 | 13 |
| 18 | Influence of interferon-gamma on isolated chondrocytes from human articular cartilage. Dose dependent inhibition of cell proliferation and proteoglycan synthesis. | 1993 | 11 |
| 19 | Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies. | 1984 | 10 |
| 20 | Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study. | 1987 | 9 |
About Veys Em
Veys Em is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging, Immunology, Genetics and Epidemiology, having authored 34 papers that have together received 912 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (9 papers), Rheumatoid Arthritis Research and Therapies (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Osteoarthritis Treatment and Mechanisms (5 papers), Systemic Lupus Erythematosus Research (4 papers), Proteoglycans and glycosaminoglycans research (3 papers), Inflammatory mediators and NSAID effects (2 papers) and Therapeutic Uses of Natural Elements (2 papers). The work is most often cited by research in Rheumatology (574 citations), Hematology (125 citations), Immunology (218 citations), Genetics (202 citations) and Immunology and Allergy (29 citations). Veys Em has collaborated with scholars based in Belgium. Frequent co-authors include Herman Mielants, De Vos M, Gust Verbruggen, C Cuvelier, Claude Cuvelier, Stefan Goemaere, Lieve Gyselbrecht, Dirk Elewaut, L Schatteman and Gideon Goldstein. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.